Mice Lacking Endothelial ACE: Normal Blood Pressure With Elevated Angiotensin II

Abstract—Recently, the concept of local renin-angiotensin systems (RAS) capable of generating angiotensin II apart from the circulation has received considerable attention. To investigate this, we generated ACE 1/3 mice in which one allele of ACE is null and the second allele was engineered to express ACE on the surface of hepatocytes. ACE 1/3 mice express no endothelial ACE and lack ACE within the lungs. Their kidneys contain <7.8% the enzyme levels present in control mice. Plasma conversion of angiotensin I to angiotensin II was 43.3% normal. The baseline blood pressure and renal function of the ACE 1/3 mice were normal, probably as a function of a marked increase of both plasma angiotensin I and angiotensin II. When exposed to 2 weeks of a salt-free diet (a stress diet stimulating the RAS), blood pressure in ACE 1/3 mice decreased to 92.3±2.0 mm Hg, a level significantly lower than that of wild-type control mice. The ACE 1/3 mice demonstrate the plasticity of the RAS and show that significant compensation is required to maintain normal, basal blood pressure in a mouse with an impaired local vascular and renal RAS.

[1]  Anne K. Mongiu,et al.  Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins. , 2002, American journal of physiology. Renal physiology.

[2]  S. Germain,et al.  Expression of renin in large arteries outside the kidney revealed by human renin promoter/LacZ transgenic mouse. , 2002, The American journal of pathology.

[3]  M. Capecchi,et al.  Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure , 2002, Circulation research.

[4]  E. Lonn,et al.  The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. , 2001, The American journal of cardiology.

[5]  C. Sigmund Genetic manipulation of the renin-angiotensin system in the kidney. , 2001, Acta physiologica Scandinavica.

[6]  M. Capecchi,et al.  Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. , 2000, The Journal of clinical investigation.

[7]  T. Coffman,et al.  Angiotensin II Receptor Physiology Using Gene Targeting. , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[8]  K. Baker,et al.  The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? , 1999, Circulation research.

[9]  D. Stec,et al.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. , 1999, Physiological genomics.

[10]  S. Oparil,et al.  Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. , 1997, Hypertension.

[11]  M. Capecchi,et al.  The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. , 1997, The Journal of clinical investigation.

[12]  M. Capecchi,et al.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[13]  J. Ménard,et al.  Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. , 1995, Circulation.

[14]  J. Charles Jennette,et al.  Male–female differences in fertility and blood pressure in ACE-deficient mice , 1995, Nature.

[15]  J. Hodgin,et al.  A noninvasive computerized tail-cuff system for measuring blood pressure in mice. , 1995, Hypertension.

[16]  V. Dzau Tissue renin-angiotensin system in myocardial hypertrophy and failure. , 1993, Archives of internal medicine.

[17]  Lei Wei,et al.  The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. , 1991, The Journal of biological chemistry.

[18]  V. Dzau Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. , 1989, Journal of hypertension.

[19]  M. Lyon,et al.  Chromosome maps of man and mouse, III. , 1987, Genomics.

[20]  R. Palmiter,et al.  An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. , 1987, Genes & development.

[21]  A. Joyner,et al.  Production of chimeras and genetically defined offspring from targeted ES cells. , 1993 .

[22]  Alexandra L. Joyner,et al.  Gene targeting: a practical approach. , 1993 .

[23]  C. Baylis,et al.  Persistence of Maternal Plasma Volume Expansion in Midterm Pregnant Rats Maintained on A Zero Sodium Intake: Evidence That Early Gestational Volume Expansion does not Require Renal Sodium Retention , 1990 .